These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28943566)

  • 1. Deep Ulcers in the Ileum Associated with Mycophenolate Mofetil.
    Sonoda A; Wada K; Mizukami K; Fukuda K; Shuto M; Okamoto K; Ogawa R; Okimoto T; Murakami K
    Intern Med; 2017 Nov; 56(21):2883-2886. PubMed ID: 28943566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
    Guo YW; Gu HY; Abassa KK; Lin XY; Wei XQ
    World J Gastroenterol; 2016 Jun; 22(24):5616-22. PubMed ID: 27350740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminal Ileac Ulcers Mimicked Post-transplantation Lymphoproliferative Disorder in a Heart Recipient Treated With Everolimus: A Case Report.
    Iwasaki K; Seguchi O; Mochizuki H; Kimura Y; Toda K; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Yanase M; Matsumoto Y; Fukushima S; Fujita T; Kobayashi J; Fukushima N
    Transplant Proc; 2018 Dec; 50(10):4053-4056. PubMed ID: 30577313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate-induced oral ulcers: Case report and literature review.
    Asare K; Gatzke CB
    Am J Health Syst Pharm; 2020 Mar; 77(7):523-528. PubMed ID: 32058566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient.
    Weng RR; Foster CE; Hsieh LL; Patel PR
    Am J Health Syst Pharm; 2011 Apr; 68(7):585-8. PubMed ID: 21411799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of oral ulcerations associated with mycophenolate mofetil in kidney transplantation.
    Tenório JR; Tuma M; Martins F; Ortega KL; Cristelli M; Gallottini M
    Spec Care Dentist; 2020 Nov; 40(6):605-610. PubMed ID: 32950040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.
    Vanhove T; Kuypers D; Claes KJ; Evenepoel P; Meijers B; Naesens M; Vanrenterghem Y; Cornelis T; Bammens B
    Transpl Int; 2013 Aug; 26(8):813-21. PubMed ID: 23746202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant Gastric Ulcers: An Unusual Culprit.
    Abbass A; Khalid S; Boppana V; Hanson J; Lin H; McCarthy D
    Dig Dis Sci; 2020 Oct; 65(10):2811-2817. PubMed ID: 32875528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.
    Cooper M; Deering KL; Slakey DP; Harshaw Q; Arcona S; McCann EL; Rasetto FA; Florman SS
    Transplantation; 2009 Aug; 88(4):514-20. PubMed ID: 19696634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.
    Sarmiento JM; Munn SR; Paya CV; Velosa JA; Nguyen JH
    Clin Transplant; 1998 Oct; 12(5):371-4. PubMed ID: 9787943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium.
    Ortega F; Sánchez-Fructuoso A; Cruzado JM; Gómez-Alamillo JC; Alarcón A; Pallardó L; Morales JM; Oliver J; Guinea G;
    Transplantation; 2011 Aug; 92(4):426-32. PubMed ID: 21760569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients.
    Machnicki G; Ricci JF; Brennan DC; Schnitzler MA
    Pharmacoeconomics; 2008; 26(11):951-67. PubMed ID: 18850764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
    Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
    Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.